Author

Ulrike von Arnim 1

1 Otto V. Guericke University, Magdeburg, Germany

A novel budesonide orodispersible tablet formulation is highly effective to maintain endoscopic inflammatory remission and even complete endoscopic remission in adult patients with eosinophilic esophagitis: Results from the 48-weeks, double-blind, placebo-controlled pivotal EOS-2 trial

Luc Biedermann, Alfredo J. Lucendo, Stephan Miehlke, Christoph Schlag, Cecilio Santander Vaquero, Constanza Ciriza De Los Ríos, Dirk Hartmann, Ahmed Madisch, Petr Hruz, Jamal Hayat, Ulrike von Arnim, Arjan Bredenoord, Ralph Müller, Roland Greinwald, Alain Schoepfer, Stephen E. Attwood, Alex Straumann

A RANDOMIZED, DOUBLE-BLIND, DOUBLE-DUMMY, PLACEBO-CONTROLLED, EUROPEAN MULTICENTRE TRIAL OF TWO NEW BUDESONIDE FORMULATIONS FOR TREATMENT OF ACTIVE EOSINOPHILIC ESOPHAGITIS

Petr Hruz, Stephan Miehlke, Ulrike von Arnim, Ahmed Madisch, Michael Vieth, Christiane Fibbe, Henning Wittenburg, Hans-Dieter Allescher, Max Reinshagen, Stefan Schubert, Jan Tack, Michaela Müller, Alexander J. Eckardt, Patrick Krummenerl, Joris Arts, Karin Dilger, Roland Greinwald, Alex Straumann

Budesonide orodispersible tablets are superior to maintain and even further improve quality of life in adult patients with eosinophilic esophagitis: Results from the 48-weeks, double-blind, placebo-controlled pivotal EOS-2 trial

Christoph Schlag, Luc Biedermann, Alfredo J. Lucendo, Stephan Miehlke, Cecilio Santander Vaquero, Constanza Ciriza De Los Ríos, Dirk Hartmann, Ahmed Madisch, Petr Hruz, Jamal Hayat, Ulrike von Arnim, Arjan Bredenoord, Ralph Müller, Roland Greinwald, Alain Schoepfer, Stephen E. Attwood, Alex Straumann

Budesonide orodispersible tablets are superior to maintain combined clinical and histological remission in adult patients with eosinophilic esophagitis: Results from the 48-weeks, double-blind, placebo-controlled pivotal EOS-2 trial

Alex Straumann, Alfredo J. Lucendo, Stephan Miehlke, Michael Vieth, Christoph Schlag, Luc Biedermann, Cecilio Santander Vaquero, Constanza Ciriza De Los Ríos, Dirk Hartmann, Ahmed Madisch, Petr Hruz, Jamal Hayat, Ulrike von Arnim, Arjan Bredenoord, Stefan Schubert, Ralph Müller, Roland Greinwald, Alain Schoepfer, Stephen

EFFICACY AND SAFETY OF BUDESONIDE ORODISPERSIBLE TABLETS IN ACTIVE EOSINOPHILIC OESOPHAGITIS: RESULTS FROM A RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PIVOTAL, EUROPEAN MULTICENRE TRIAL (EOS-1)

Alex Straumann, Alfredo J. Lucendo, Stephan Miehlke, Michael Vieth, Christoph Schlag, Ulrike von Arnim, Javier Molina Infante, Dirk Hartmann, Arjan Bredenoord, Constanza Ciriza De Los Ríos, Stefan Schubert, Stefan Brueckner, Ahmed Madisch, Jamal Hayat, Jan Tack, Alain Schoepfer, Roland Greinwald, Ralph Mueller, Stephen E.

Guidelines on eosinophilic esophagitis: evidence-based statements and recommendations for diagnosis and management in children and adults

Javier Molina Infante, Alfredo J. Lucendo, Ángel Arias Arias, Ulrike von Arnim, Arjan Bredenoord, Christian Bussmann, Jorge Amil Dias, Mogens Bove, Jesús González-Cervera, Helen Larsson, Stephan Miehlke, Alexandra Papadopoulou, Joaquin Rodríguez Sánchez, Alberto Ravelli, Jukka Ronkainen, Cecilio Santander, Alain Schoepfer;;

Pathophysiology and Diagnosis of EoE

Ulrike von Arnim

VEDOLIZUMAB PROVIDES CLINICAL BENEFIT OVER ONE YEAR IN PATIENTS WITH REFRACTORY INFLAMMATORY BOWEL DISEASE - RESULTS OF A PROSPECTIVE MULTICENTER OBSERVATIONAL STUDY

Raja Atreya, Daniel C. Baumgart, Tony Bruns, Axel Dignass, Katrin Ende, Jochen Hampe, Franz Hartmann, Christian Langbein, Jochen Maul, Markus F. Neurath, Jan C. Preiss, Renate Schmelz, Carsten Schmidt, Hermann Schulze, Britta Siegmund, Niels Teich, Ulrike von Arnim, Andreas Stallmach

Item 1 - 8 / 9
1